Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis - The Lancet Diabetes & Endocrinology
Evaluation of low-cost sensors for quantitative personal exposure monitoring - ScienceDirect
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial
Defining priority medical devices for cancer management: a WHO initiative - The Lancet Oncology
Biosensor-based therapy powered by synthetic biology - ScienceDirect
JPM, Free Full-Text
Assessing Polymorphic Purity of Rifampicin in Double and Triple-Drug Fixed- Dose Combination Products - Journal of Pharmaceutical Sciences
Applied Sciences, Free Full-Text
Innovation for infection prevention and control—revisiting Pasteur's vision - The Lancet
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge - ScienceDirect